Optiver Holding
RLAY icon

Optiver Holding’s Relay Therapeutics RLAY Stock Holding History

Optiver Holding’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4K Buy
+767
New +$11.1K ﹤0.01% 1644
2025
Q4 		– Sell
-1,228
Closed -$6.41K – 2906
2025
Q3 		$6.41K Buy
+1,228
New +$4.68K ﹤0.01% 1558

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Optiver Holding's RLAY Position: Q2 2026 in Review

Optiver Holding opened a new position in Relay Therapeutics (RLAY) in Q2 2026: 767 shares worth $14.4K. The stake represents ﹤0.01% of the portfolio and ranks #1644 among its holdings. This is a return to the name: Optiver Holding previously reported a position in RLAY as recently as Q3 2025.

Optiver Holding first reported a position in RLAY in Q3 2025 and has held it in 2 quarters since. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Optiver Holding held 767 shares of Relay Therapeutics worth $14.4K as of Q2 2026.
  • Relay Therapeutics was a new Optiver Holding position in Q2 2026.
  • Relay Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1644 holding.
  • Optiver Holding first reported a position in Relay Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.